The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2024

Filed:

Nov. 15, 2021
Applicant:

Exthera Medical Corporation, Martinez, CA (US);

Inventors:

Robert S. Ward, Martinez, CA (US);

Keith R. McCrea, Martinez, CA (US);

Lakhmir (Mink) Chawla, Martinez, CA (US);

Assignee:

EXTHERA MEDICAL CORPORATION, Martinez, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/727 (2006.01); A61K 31/726 (2006.01); A61K 31/728 (2006.01); A61K 31/737 (2006.01); A61M 1/36 (2006.01); A61P 7/00 (2006.01); B01J 20/24 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3689 (2014.02); A61K 31/726 (2013.01); A61K 31/727 (2013.01); A61K 31/728 (2013.01); A61K 31/737 (2013.01); A61P 7/00 (2018.01); B01J 20/24 (2013.01);
Abstract

The present invention provides methods and devices for augmenting impaired glycocalyx barrier function in a subject in need thereof by contacting a sample (e.g., blood) obtained from the subject with a glycocalyx-mimetic adsorption media. The adsorption media includes glycosaminoglycan structures and, optionally, proteoglycan core proteins, which are conducive to enhancing and/or restoring the impaired glycocalyx barrier function in a sample. The contacted sample is subsequently separated from the adsorption media, producing a treated sample that can be infused into the subject. Methods and devices for treating a patient suffering from a disease associated with glycocalyx barrier dysfunction are also provided herein.


Find Patent Forward Citations

Loading…